The civic record
Read. Follow. Verify.Shandra Eisenga Human Cell and Tissue Product Safety Act
Last action · June 24, 2025: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
This bill proposes new federal safety requirements for s to improve oversight and patient protection. It has been introduced in the House and referred to the Senate Committee on Health, Education, Labor, and Pensions for review.
The legislation aims to establish stricter safety standards for biological products, which directly impacts the regulatory requirements for tissue banks and the safety protocols for patients receiving these products.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Patients
Patients receiving human cell and tissue products may be subject to new safety standards and oversight protocols established by this legislation.
Tissue banks
Tissue banks would be required to comply with new federal safety regulations regarding the processing and distribution of human cell and tissue products.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What is the purpose of the Shandra Eisenga Human Cell and Tissue Product Safety Act?
What is the current status of the bill?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently passed chamber. The next step in the legislative lifecycle is Law.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Increased focus on tissue safety
The introduction of this act suggests a legislative effort to tighten federal oversight of the human cell and tissue product industry.
Connected Entities
Sources
www.congress.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools